@article{fagard:hal-00875207,
TITLE = {Long-term efficacy and safety of raltegravir, etravirine, and darunavir/ritonavir in treatment-experienced patients: week 96 results from the ANRS 139 TRIO trial.},
AUTHOR = {Fagard, Catherine and Colin, C{\'e}line and Charpentier, Charlotte and Rami, Agathe and Jacomet, Christine and Yeni, Patrick and Vittecoq, Daniel and Katlama, Christine and Molina, Jean-Michel and Descamps, Diane and Ch{\^e}ne, Genevi{\`e}ve and Yazdanpanah, Yazdan and Michelet, Christian},
URL = {https://hal.science/hal-00875207},
JOURNAL = {Journal of Acquired Immune Deficiency Syndromes - JAIDS},
PUBLISHER = {Lippincott, Williams \& Wilkins},
VOLUME = {59},
NUMBER = {5},
PAGES = {489-93},
YEAR = {2012},
MONTH = Apr, DOI = {10.1097/QAI.0b013e31824bb720},
KEYWORDS = {multidrug resistant ; HIV ; raltegravir ; etravirine ; darunavir/ritonavir},
HAL_ID = {hal-00875207},
HAL_VERSION = {v1},
}